Medical Instruments & Supplies / Healthcare Consumer Products
Strategic Profile
The company operates across four segments: wound care, incontinence management, infection management, and other group activities. Its primary clients include hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The company operates as a subsidiary of Paul Hartmann Finance B.V.
Cyborg Score Rationale
IVF Hartmann demonstrates solid fundamentals as an established medical supplies provider with 150+ years of heritage and international reach. The company maintains reasonable profitability metrics with a PE ratio of 17.61 and dividend yield of 4.53%, though limited public data on growth trajectory constrains the assessment.
Top Insights
Legacy Swiss medical supplies company with 154-year operational history and strong institutional clientele across hospitals and healthcare facilities
Operates within subsidiary structure of Paul Hartmann Finance, indicating private equity backing and potential for operational optimization
Dividend yield of 4.53% suggests focus on cash returns to shareholders, appealing to income investors
Limited market cap (~CHF 324-400M) indicates niche positioning in specialized medical/hygiene products rather than mass-market competition
Named Competitors
Medical Devices & Supplies — Large-cap diversified medical device manufacturer